CentoWebinar - "Back to Business: How to Deploy Preventative Coronavirus Testing at Your Organization"
Over the past 15 years, CENTOGENE has been committed to delivering life-changing medical solutions for patients around the world. As soon as the coronavirus hit, we saw it as our responsibility to leverage our medical expertise, impact, and resources to support the fight against this global pandemic.
Join us as we share the latest insights into the importance of large-scale, preventative coronavirus testing and our blueprint for successfully deploying it at your organization. With actionable steps and proven success stories, you are just one webinar away to being back in business.
Questions and discussion are more than welcome throughout the webinar.
- The crucial role of large-scale, preventive coronavirus testing
- A blueprint for rapid and convenient coronavirus testing for your customers and employees
- Case study: Bringing customers back to Frankfurt Airport & Lufthansa
- Case study: Bringing employees back to CENTOGENE offices
- Case study: Bringing students back to school
Date & Time:
Tuesday, 15 September 2020
See when the event will take place in your time zone.
Unable to attend the webinar? By registering, you will receive a recording of the webinar even if you could not attend the event. If you encounter any problems, please contact us at webinars(at)centogene(dot)com.
Dr. Peter Bauer, Chief Genomic Officer
Prof. Peter Bauer, MD, serves as CENTOGENE’s Chief Genomic Officer, where he combines clinical and medical understanding in genetic testing with an excellent knowledge of the latest scientific development, based on his extraordinary experience, especially in high-throughput genetic testing using next-generation sequencing.
Prof. Bauer received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Additionally, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics, and sequencing technology.
Recording available soon!